In this Cancer Matters podcast, Dr Bill Nelson and Dr Emmanuel Antonarakis explain how PARP Inhibitors work and their use in treating some types of prostate cancer.
On Target with Dr Akila Viswanathan – ASTRO Clinical Guidelines on Radiation Therapy for Cervical CancerPosted by Clinton | podcast
In this On Target podcast, Dr Akila Viswanathan and Dr Junzo Chino from the Duke Cancer Institute examine the American Society for Radiation Oncology Clinical Guidelines on Radiation Therapy for Cervical Cancer. To read the guidelines, visit: https://www.astro.org/Patient-Care-and-Research/Clinical-Practice-Statements/Cervical-Cancer-Guideline
Aug 4, 2020 No comments
In this Cancer Matters podcast, Dr Bill Nelson speaks with Dr Mark Yarchoan about the diagnosis and treatment of liver cancer.
Jul 30, 2020 No comments
In the latest Cancer Matters podcast, Dr Bill Nelson speaks with Dr Mario Eisenberger about treating advanced-stage prostate cancer.
Jul 23, 2020 No comments
In this Cancer Matters podcast, Dr Bill Nelson talks with Dr Ken Cooke about the success of pediatric bone marrow transplants.
Jul 16, 2020 No comments
In the latest On Target podcast, Dr Akila Viswanathan speaks Dr Harry Quon, the Co-Director of the Johns Hopkins Head and Neck Cancer Multidisciplinary Clinic.
Jul 14, 2020 No comments
Johns Hopkins Kimmel Cancer Center investigators report they have uncovered a new mechanism by which invasive breast cancer cells evade the immune system to metastasize, or spread, to other areas of the body. They propose that therapies targeting this process could be developed to halt or prevent metastasis and reduce breast cancer deaths. Natural killer (NK) […]
Jul 10, 2020 No comments
In the latest Cancer Matters podcast, Dr Bill Nelson speaks with Dr Bert Vogelstein about shifting his work as a cancer researcher to detecting and preventing the spread of COVID-19.
Jul 9, 2020 No comments
In a research study published online June 24 in the journal Clinical Neurology and Neurosurgery, the research team found that routine radiation treatment after surgery for a rare and slow-growing type of brain tumor called pleomorphic xanthoastrocytoma, or PXAs, was associated with markedly worse overall survival. The researchers reviewed 550 PXA patients from the National […]
Jul 8, 2020 No comments
A new research study published June 20 in Neuropathology and Applied Neurobiology found key biological differences between aggressive and more indolent, less harmful brain tumors that develop in neurofibromatosis type 1 (NF1) patients. NF1 is a genetic disorder that can predispose those affected to benign and cancerous nervous system tumors. “These findings may lead to […]
Jul 7, 2020 No comments